The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

OrbusNeich, Boston Scientific Settle Patent Litigation

Tuesday, September 17, 2013

OrbusNeich, Boston Scientific Settle Patent Litigation

04:00 EDT Tuesday, September 17, 2013

FORT LAUDERDALE, Fla. and NATICK, Mass., Sept. 17, 2013 /PRNewswire/ -- OrbusNeich Medical Inc. and Boston Scientific Corporation (NYSE: BSX) have settled all stent-related litigation between the companies.  The agreement resolves cases brought by the parties in Germany, the Netherlands, Ireland, the United Kingdom and the United States.  The agreement, which includes a one-time payment from Boston Scientific to OrbusNeich, settles all stent-related disputes between the companies and does not include future financial obligations.

About OrbusNeich OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Current products are the world's first dual therapy stent, the COMBO? Dual Therapy Stent, and the world's first pro-healing stent, the Genous? Stent. Other products include stents and balloons marketed under the names of Azule?, R stent, Scoreflex?, Sapphire?, Sapphire II and Sapphire NC. OrbusNeich is headquartered in Hong Kong and has operations in Shenzhen, China; Fort Lauderdale, Fla.; Hoevelaken, The Netherlands; and Tokyo, Japan. OrbusNeich supplies medical devices to interventional cardiologists in more than 60 countries. For more information, visit www.OrbusNeich.com.

About Boston ScientificBoston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS: 

OrbusNeich Medical:

Boston Scientific:

Jamie Moser / Bryan Darrow

Joele Frank, Wilkinson Brimmer Katcher

Peter Lucht

212-355-4449

Media Relations

508-650-8796

media@bsci.com

Michael Campbell

508-650-8023

Investor Relations

investor_relations@bsci.com

 

 

 

SOURCE OrbusNeich Medical Inc.; Boston Scientific Corporation

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Advertising Privacy
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections